- Home
- RLGT vs ENGN Comparison
RLGT vs ENGN Comparison
Compare RLGT & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLGT
- ENGN
- Stock Information
- Founded
- RLGT 2001
- ENGN 1999
- Country
- RLGT United States
- ENGN Canada
- Employees
- RLGT N/A
- ENGN N/A
- Industry
- RLGT Oil Refining/Marketing
- ENGN
- Sector
- RLGT Consumer Discretionary
- ENGN
- Exchange
- RLGT Nasdaq
- ENGN Nasdaq
- Market Cap
- RLGT 283.4M
- ENGN 379.3M
- IPO Year
- RLGT N/A
- ENGN N/A
- Fundamental
- Price
- RLGT $6.08
- ENGN $6.04
- Analyst Decision
- RLGT Strong Buy
- ENGN Buy
- Analyst Count
- RLGT 1
- ENGN 7
- Target Price
- RLGT $8.00
- ENGN $20.29
- AVG Volume (30 Days)
- RLGT 163.3K
- ENGN 278.6K
- Earning Date
- RLGT 11-10-2025
- ENGN 12-18-2025
- Dividend Yield
- RLGT N/A
- ENGN N/A
- EPS Growth
- RLGT 118.75
- ENGN N/A
- EPS
- RLGT 0.35
- ENGN N/A
- Revenue
- RLGT $902,696,000.00
- ENGN N/A
- Revenue This Year
- RLGT $2.96
- ENGN N/A
- Revenue Next Year
- RLGT $2.98
- ENGN N/A
- P/E Ratio
- RLGT $17.37
- ENGN N/A
- Revenue Growth
- RLGT 12.49
- ENGN N/A
- 52 Week Low
- RLGT $5.44
- ENGN $2.65
- 52 Week High
- RLGT $7.94
- ENGN $9.65
- Technical
- Relative Strength Index (RSI)
- RLGT 50.72
- ENGN 35.10
- Support Level
- RLGT $5.93
- ENGN $6.62
- Resistance Level
- RLGT $6.20
- ENGN $7.49
- Average True Range (ATR)
- RLGT 0.12
- ENGN 0.80
- MACD
- RLGT 0.01
- ENGN -0.33
- Stochastic Oscillator
- RLGT 57.61
- ENGN 3.76
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.